ALKAL Fundamental Analysis - KALRAY SADIR

Fundamental Rating

ALKAL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 60 industry peers in the Semiconductors & Semiconductor Equipment industry. ALKAL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALKAL is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALKAL had negative earnings in the past year.

ALKAL had a negative operating cash flow in the past year.

ALKAL had negative earnings in each of the past 5 years.

In the past 5 years ALKAL reported 4 times negative operating cash flow.

1.2 Ratios

ALKAL has a worse Return On Assets (-21.36%) than 86.67% of its industry peers.

The Return On Equity of ALKAL (-42.95%) is worse than 85.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-21.36%
ROE	-42.95%
ROIC	N/A

ROA(3y)-19.53%

ROA(5y)-23.68%

ROE(3y)-41.1%

ROE(5y)-44.77%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 123.33%, ALKAL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

ALKAL's Gross Margin has declined in the last couple of years.

ALKAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	123.33%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.53%

GM growth 5Y-27.47%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALKAL does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALKAL has been increased compared to 1 year ago.

Compared to 5 years ago, ALKAL has more shares outstanding

The debt/assets ratio for ALKAL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.23, we must say that ALKAL is in the distress zone and has some risk of bankruptcy.

ALKAL has a Altman-Z score of -1.23. This is amonst the worse of the industry: ALKAL underperforms 85.00% of its industry peers.

A Debt/Equity ratio of 0.15 indicates that ALKAL is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.15, ALKAL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	-1.23

ROIC/WACCN/A

WACC10.25%

2.3 Liquidity

ALKAL has a Current Ratio of 0.66. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of ALKAL (0.66) is worse than 86.67% of its industry peers.

A Quick Ratio of 0.55 indicates that ALKAL may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.55, ALKAL is doing worse than 85.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.66
Quick Ratio	0.55

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALKAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.97%, which is quite impressive.

ALKAL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.40%.

The Revenue has been growing by 81.37% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)50.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.21%

Revenue 1Y (TTM)1.4%

Revenue growth 3Y157.5%

Revenue growth 5Y81.37%

Sales Q2Q%-27.77%

3.2 Future

ALKAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.31% yearly.

ALKAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.29% yearly.

EPS Next Y54.99%

EPS Next 2Y29.97%

EPS Next 3Y24.31%

EPS Next 5YN/A

Revenue Next Year-35.79%

Revenue Next 2Y-20.64%

Revenue Next 3Y-1.88%

Revenue Next 5Y45.29%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKAL. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALKAL. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALKAL's earnings are expected to grow with 24.31% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y29.97%

EPS Next 3Y24.31%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALKAL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KALRAY SADIR

EPA:ALKAL (11/25/2025, 7:00:00 PM)

0.697

-0.01 (-1.83%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)10-02 2025-10-02

Earnings (Next)N/A N/A

Inst Owners5.67%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap9.03M

Revenue(TTM)21.79M

Net Income(TTM)-14.28M

Analysts40

Price Target0.51 (-26.83%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)115.07%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.41
P/FCF	N/A
P/OCF	N/A
P/B	0.27
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.12

EYN/A

EPS(NY)-0.69

Fwd EYN/A

FCF(TTM)-2.86

FCFYN/A

OCF(TTM)-0.28

OCFYN/A

SpS1.68

BVpS2.56

TBVpS-0.8

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-21.36%
ROE	-42.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	123.33%
FCFM	N/A

ROA(3y)-19.53%

ROA(5y)-23.68%

ROE(3y)-41.1%

ROE(5y)-44.77%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.53%

GM growth 5Y-27.47%

F-Score3

Asset Turnover0.33

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	175.99%
Cap/Sales	153.59%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.66
Quick Ratio	0.55
Altman-Z	-1.23

F-Score3

WACC10.25%

ROIC/WACCN/A

Cap/Depr(3y)126.32%

Cap/Depr(5y)90.91%

Cap/Sales(3y)102.68%

Cap/Sales(5y)192.5%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)50.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.21%

EPS Next Y54.99%

EPS Next 2Y29.97%

EPS Next 3Y24.31%

EPS Next 5YN/A

Revenue 1Y (TTM)1.4%

Revenue growth 3Y157.5%

Revenue growth 5Y81.37%

Sales Q2Q%-27.77%

Revenue Next Year-35.79%

Revenue Next 2Y-20.64%

Revenue Next 3Y-1.88%

Revenue Next 5Y45.29%

EBIT growth 1Y17.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year131.25%

EBIT Next 3Y33.5%

EBIT Next 5YN/A

FCF growth 1Y-153.22%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1903.89%

OCF growth 3YN/A

OCF growth 5YN/A

KALRAY SADIR / ALKAL.PA FAQ

Can you provide the ChartMill fundamental rating for KALRAY SADIR?

ChartMill assigns a fundamental rating of 2 / 10 to ALKAL.PA.

What is the valuation status of KALRAY SADIR (ALKAL.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to KALRAY SADIR (ALKAL.PA). This can be considered as Overvalued.

Can you provide the profitability details for KALRAY SADIR?

KALRAY SADIR (ALKAL.PA) has a profitability rating of 1 / 10.

What is the expected EPS growth for KALRAY SADIR (ALKAL.PA) stock?

The Earnings per Share (EPS) of KALRAY SADIR (ALKAL.PA) is expected to grow by 54.99% in the next year.

KALRAY SADIR (ALKAL.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

KALRAY SADIR / ALKAL.PA FAQ

Can you provide the ChartMill fundamental rating for KALRAY SADIR?

What is the valuation status of KALRAY SADIR (ALKAL.PA) stock?

Can you provide the profitability details for KALRAY SADIR?

What is the expected EPS growth for KALRAY SADIR (ALKAL.PA) stock?